Israel’s Cell Cure Neurosciences has been awarded a grant of NIS 6.1 million from the Office of the Chief Scientist. The grant will help finance the human clinical trials in 2014 of OpRegen, a cell-based therapeutic product for the treatment of age-related macular degeneration.
http://www.globes.co.il/serveen/globes/docview.asp?did=1000904027&fid=1725